Export of Alcohol-based hand sanitisers banned

The Centre government has banned the export of alcohol-based hand sanitisers to other countries also suffering with coronavirus pandemic.
The Directorate General of Foreign Trade (DGFT) that comes under the Ministry of Commerce and Industry said in a notification that “Alcohol-based hand sanitisers are prohibited for export.”

The step by the government is intended to ensure and boost the availability of hand sanitisers in the domestic market which is causing shortage amid the outbreak of the highly contagious Covid-19 disease since, Sanitisers has been placed under essential commodity by the Government in the fight against the covid-19 and are much useful also as a disinfectant to prevent the spread.

Sanitisers of the major brands are not available in the market properly till date due to the extended lockdown and shortage in the supply.
Reports of people drinking sanitisers due to the high alcohol content have also emerged across India as people were not able to purchase liquor due to lockdown. Last month, a 29-year-old research student died in Hoysala Nagar of Dharwad district in Karnataka after consuming a hand sanitiser and cough syrup.
Health officials have repeatedly appealed to people not to consume sanitisers or cough syrups.

  • Related Posts

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre